🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study with ALTB-268 will determine the safety, tolerability, pharmacok...
Status
Active Not Recruiting
Location
Syneos Health Clinical Research Services, LLC
Start Date
2025-11-17
Trial ID
NCT07350577
ZM-H1505R is an investigational drug developed by Shanghai Zhimeng Biopharm...
Status
Completed
Location
Frontage Clinical Services
Start Date
2020-02-17
Trial ID
NCT04220801
Treatments Being Tested
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This randomized, double-blind, placebo-controlled, single ascending dose st...
Status
Completed
Location
Changi General Hospital; Clinical Trial & Research unit
Start Date
2013-12
Trial ID
NCT02015715
To evaluate the safety and tolerability of single dose of SYH2082 Injection...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Nanjing University Medical School
Start Date
2026-04-13
Trial ID
NCT07736404
Treatments Being Tested
The purpose of the study is to evaluate the safety and tolerability of sing...
Status
Completed
Location
SGS Stuivenberg
Start Date
2009-12
Trial ID
NCT01023321
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics o...
Status
Unknown
Location
Peking University Third Hospital
Start Date
2024-04-10
Trial ID
NCT06344533
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested